stella
beta
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia — Stella
Recruiting
Back to Cachexia-Anorexia Syndrome trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov